Citation: | Shi Xinlin, Wang Jizhou, Jiang Hongchi, et al. Research progress of vascular factors affecting recurrence after liver transplantation in patients with hepatocellular carcinoma[J]. ORGAN TRANSPLANTATION, 2019, 10(6): 727-730. doi: 10.3969/j.issn.1674-7445.2019.06.017 |
[1] |
BARBHUIYA MA, MIRANDO AC, SIMONS BW, et al. Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma[J]. Oncotarget, 2017, 8(60):101520-101534. DOI: 10.18632/oncotarget.21148.
|
[2] |
FOLKMAN J. Tumor angiogenesis: therapeutic implications[J]. N Engl J Med, 1971, 285(21):1182-1186. doi: 10.1056/NEJM197111182852108
|
[3] |
SHIMIZU A, ZANKOV DP, KUROKAWA-SEO M, et al. Vascular endothelial growth factor-a exerts diverse cellular effects via small g proteins, rho and rap[J]. Int J Mol Sci, 2018, 19(4). pii: E1203. DOI: 10.3390/ijms19041203.
|
[4] |
ZHANG W, KIM R, QUINTINI C, et al. Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation[J]. Liver Transpl, 2015, 21(1):101-111. DOI: 10.1002/lt.24013.
|
[5] |
ZHAN P, QIAN Q, YU LK. Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a Meta-analysis[J]. Hepatobiliary Surg Nutr, 2013, 2(4):209-215. DOI: 10.3978/j.issn.2304-3881.2013.06.07.
|
[6] |
FAILLACI F, MARZI L, CRITELLI R, et al. Liver angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after hepatitis C virus direct-acting antivirals[J]. Hepatology, 2018, 68(3):1010-1024. DOI: 10.1002/hep.29911.
|
[7] |
FIORENTINO M, ALTIMARI A, RAVAIOLI M, et al. Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation[J]. Clin Cancer Res, 2004, 10(5):1789-1795. doi: 10.1158/1078-0432.CCR-1149-3
|
[8] |
ATAIDE EC, PERALES SR, SILVA MG, et al. Immunoexpression of heat shock protein 70, glypican 3, glutamine synthetase, and beta-catenin in hepatocellular carcinoma after liver transplantation: association between positive glypican 3 and beta-catenin with the presence of larger nodules[J]. Transplant Proc, 2017, 49(4):858-862. DOI: 10.1016/j.transproceed.2017.01.048.
|
[9] |
MAASS T, THIERINGER FR, MANN A, et al. Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis[J]. Int J Cancer, 2011, 128(6):1259-1268. DOI: 10.1002/ijc.25469.
|
[10] |
WEI T, ZHANG LN, LV Y, et al. Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinoma[J]. Oncotarget, 2014, 5(21):10307-10317. doi: 10.18632/oncotarget.2537
|
[11] |
GOYAL L, MUZUMDAR MD, ZHU AX. Targeting the HGF/c-MET pathway in hepatocellular carcinoma[J]. Clin Cancer Res, 2013, 19(9):2310-2318. DOI: 10.1158/1078-0432.CCR-12-2791.
|
[12] |
CAI H, SAIYIN H, LIU X, et al. Nogo-B promotes tumor angiogenesis and provides a potential therapeutic target in hepatocellular carcinoma[J]. Mol Oncol, 2018, 12(12):2042-2054. DOI: 10.1002/1878-0261.12358.
|
[13] |
郭晓东, 孟繁平, 熊璐.HIF-1α的表达在肝移植后肝癌复发与转移中的意义[J].现代生物医学进展, 2011, 11(5):876-879. http://d.old.wanfangdata.com.cn/Periodical/swcx201105022
GUO XD, MENG FP, XIONG L. Clinical significance of HIF-1α expression in recurrence and metastasis of patients with hepatocellular carcinoma undergoing liver transplantation[J]. Prog Mod Biomed, 2011, 11(5):876-879. http://d.old.wanfangdata.com.cn/Periodical/swcx201105022
|
[14] |
罗来邦, 杨华, 罗丽芳, 等.Vasohibin-2与肝癌肝移植术后复发转移及预后的关系[J].实用癌症杂志, 2017, 32(3):370-374. doi: 10.3969/j.issn.1001-5930.2017.03.007
DOI: 10.3969/j.issn.1001-5930.2017.03.007. LUO LB, YANG H, LUO LF, et al. Correlation between expression of vasohibin-2 and recurrence/metastasis and prognosis of HCC liver transplant[J]. Pract J Cancer, 2017, 32(3):370-374. DOI: 10.3969/j.issn.1001-5930.2017.03.007.
|
[15] |
李慧, 汪根树, 郑俊, 等.Zwint高表达对肝癌细胞增殖和肝癌肝移植预后的影响[J].器官移植, 2018, 9(2):122-129. doi: 10.3969/j.issn.1674-7445.2018.02.006
DOI: 10.3969/j.issn.1674-7445.2018.02.006. LI H, WANG GS, ZHENG J, et al. Effect of high expression of Zwint on the proliferation of hepatoma cells and the prognosis of liver transplantation for hepatocellular carcinoma[J]. Organ Transplant, 2018, 9(2):122-129. DOI: 10.3969/j.issn.1674-7445.2018.02.006.
|
[16] |
曹毅, 吕立志, 江艺, 等.CNTN-1和VEGF-C表达水平与肝癌肝移植术后复发转移及预后的关系[J].器官移植, 2017, 8(2):154-160. doi: 10.3969/j.issn.1674-7445.2017.02.012
DOI: 10.3969/j.issn.1674-7445.2017.02.012. CAO Y, LYU LZ, JIANG Y, et al. Relationship between CNTN-1 and VEGF-C expression levels and recurrence, metastasis and prognosis of hepatocellular carcinoma patients after liver transplantation [J]. Organ Transplant, 2017, 8(2):154-160. DOI: 10.3969/j.issn.1674-7445.2017.02.012.
|
[17] |
BOIGE V, MALKA D, BOURREDJEM A, et al. Efficacy, safety, and biomarkers of single-agent bevacizumab therapy in patients with advanced hepatocellular carcinoma[J]. Oncologist, 2012, 17(8):1063-1072. DOI: 10.1634/theoncologist.2011-0465.
|
[18] |
QI HL, ZHUANG BJ, LI CS, et al. Peri-operative use of sorafenib in liver transplantation: a time-to-event Meta-analysis[J]. World J Gastroenterol, 2015, 21(5):1636-1640. DOI: 10.3748/wjg.v21.i5.1636.
|
[19] |
JUNG DH, TAK E, HWANG S, et al. Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence[J]. Liver Transpl, 2018, 24(7):932-945. DOI: 10.1002/lt.25191.
|
[20] |
QU Z, JIANG C, WU J, et al. Lenalidomide induces apoptosis and inhibits angiogenesis via caspase-3 and VEGF in hepatocellular carcinoma cells[J]. Mol Med Rep, 2016, 14(5):4781-4786. DOI: 10.3892/mmr.2016.5797.
|
[21] |
RODRÍGUEZ-PERÁLVAREZ M, TSOCHATZIS E, NAVEAS MC, et al. Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma[J]. J Hepatol, 2013, 59(6):1193-1199. DOI: 10.1016/j.jhep.2013.07.012.
|
[22] |
CHOLONGITAS E, MAMOU C, RODRÍGUEZ-CASTRO KI, et al. Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review[J]. Transpl Int, 2014, 27(10):1039-1049. DOI: 10.1111/tri.12372.
|
[23] |
LI C, WU X, ZHANG H, et al. A huaier polysaccharide restrains hepatocellular carcinoma growth and metastasis by suppression angiogenesis[J]. Int J Biol Macromol, 2015, 75:115-120. DOI: 10.1016/j.ijbiomac.2015.01.016.
|
[24] |
LIN J, CHEN Y, WEI L, et al. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways[J]. Int J Oncol, 2013, 43(5):1666-1674. DOI: 10.3892/ijo.2013.2101.
|
[25] |
SÁNCHEZ RAMÍREZ J, MORERA DÍAZ Y, BEQUET-ROMERO M, et al. Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants[J]. BMC Immunol, 2017, 18(1):39. DOI: 10.1186/s12865-017-0222-z.
|